Humanwell Healthcare (Group) Co.,Ltd. (SHA: 600079)

Humanwell Healthcare (Group) Co.,Ltd. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	24,936	24,445	22,276	20,510	20,598	21,725
Other Revenue	67.05	79.84	61.67	38.69	82.45	81.2
Revenue	25,003	24,525	22,338	20,549	20,680	21,807
Revenue Growth (YoY)	3.57%	9.79%	8.71%	-0.63%	-5.17%	17.03%
Cost of Revenue	13,406	13,302	12,632	11,777	12,009	13,195
Gross Profit	11,597	11,223	9,706	8,772	8,671	8,611
Selling, General & Admin	6,399	6,168	5,827	5,327	5,084	5,342
Research & Development	1,527	1,462	966.86	810.47	767.55	591.16
Other Operating Expenses	272.77	191.75	205.86	224.56	143.78	155.69
Operating Expenses	8,215	7,894	7,057	6,411	6,015	6,116
Operating Income	3,382	3,329	2,649	2,361	2,656	2,495
Interest Expense	-359.38	-354.14	-476.57	-602.15	-833.6	-851.56
Interest & Investment Income	121.28	265.56	978.8	365.38	376.23	354.88
Currency Exchange Gain (Loss)	-18.12	45.96	123.67	-58.34	-100.37	4.72
Other Non Operating Income (Expenses)	-144.09	-129.77	120.33	-59.2	-169.14	-200.73
EBT Excluding Unusual Items	2,982	3,157	3,395	2,007	1,929	1,802
Impairment of Goodwill	-26.15	-26.15	-35.33	-42.68	-49.94	-62.99
Gain (Loss) on Sale of Investments	42.27	136.85	43.42	7.89	16.4	-9.46
Gain (Loss) on Sale of Assets	-3.33	-4.14	-51.51	26.06	-3.35	-31.3
Asset Writedown	-3.34	-24.72	-36.4	-7.17	-4.72	-6.11
Other Unusual Items	175.5	145.27	110.86	182.16	139.58	87.18
Pretax Income	3,167	3,384	3,426	2,173	2,027	1,779
Income Tax Expense	586.64	568.56	354.75	354.78	385.14	427.96
Earnings From Continuing Operations	2,580	2,815	3,071	1,818	1,642	1,351
Minority Interest in Earnings	-658.44	-680.78	-587.19	-501.05	-636.46	-508.93
Net Income	1,922	2,134	2,484	1,317	1,006	842.54
Net Income to Common	1,922	2,134	2,484	1,317	1,006	842.54
Net Income Growth	-16.63%	-14.07%	88.60%	30.96%	19.37%	-
Shares Outstanding (Basic)	1,627	1,617	1,613	1,587	1,378	1,453
Shares Outstanding (Diluted)	1,629	1,629	1,613	1,606	1,378	1,453
Shares Change (YoY)	0.43%	1.01%	0.42%	16.59%	-5.16%	11.52%
EPS (Basic)	1.18	1.32	1.54	0.83	0.73	0.58
EPS (Diluted)	1.18	1.31	1.54	0.82	0.73	0.58
EPS Growth	-16.98%	-14.94%	87.80%	12.33%	25.86%	-
Free Cash Flow	808.82	8.93	-672.27	475.78	991.85	1,228
Free Cash Flow Per Share	0.50	0.01	-0.42	0.30	0.72	0.85
Dividend Per Share	0.610	0.460	0.160	0.150	0.100	0.050
Dividend Growth	281.25%	187.50%	6.67%	50.00%	100.00%	-
Gross Margin	46.38%	45.76%	43.45%	42.69%	41.93%	39.49%
Operating Margin	13.53%	13.57%	11.86%	11.49%	12.84%	11.44%
Profit Margin	7.69%	8.70%	11.12%	6.41%	4.86%	3.86%
Free Cash Flow Margin	3.23%	0.04%	-3.01%	2.32%	4.80%	5.63%
EBITDA	4,113	4,023	3,372	3,020	3,337	3,072
EBITDA Margin	16.45%	16.40%	15.09%	14.70%	16.14%	14.09%
D&A For EBITDA	731.13	693.62	723.08	659.23	680.67	577.65
EBIT	3,382	3,329	2,649	2,361	2,656	2,495
EBIT Margin	13.53%	13.57%	11.86%	11.49%	12.84%	11.44%
Effective Tax Rate	18.52%	16.80%	10.35%	16.33%	19.00%	24.05%
Revenue as Reported	25,003	24,525	22,338	20,549	20,680	21,807

Source: S&P Capital IQ. Standard template. Financial Sources.